Dihydroergocornine
CHEBI:CHEBI_59909
Definition
Ergocornine in which a single bond replaces the double bond between positions 9 and 10.
Chemical Information
- Molecular Formula
- C31H41N5O5
- Molecular Mass
- 563.68770
- Charge
- 0
- SMILES
- [H][C@@]12Cc3c[nH]c4cccc(c34)[C@@]1([H])C[C@H](CN2C)C(=O)N[C@@]1(O[C@]2(O)N([C@@H](C(C)C)C(=O)N3CCC[C@@]23[H])C1=O)C(C)C
- InChI
- InChI=1S/C31H41N5O5/c1-16(2)26-28(38)35-11-7-10-24(35)31(40)36(26)29(39)30(41-31,17(3)4)33-27(37)19-12-21-20-8-6-9-22-25(20)18(14-32-22)13-23(21)34(5)15-19/h6,8-9,14,16-17,19,21,23-24,26,32,40H,7,10-13,15H2,1-5H3,(H,33,37)/t19-,21-,23-,24+,26+,30-,31+/m1/s1
- InChIKey
- SEALOBQTUQIVGU-QNIJNHAOSA-N
Alternative Names
- (10alphaH)-12'-hydroxy-3',6',18-trioxo-2',5'alpha-di(propan-2-yl)-9,10-dihydroergotaman
- 9,10-dihydroergocornine
Treatment Applications
-
cerebrooculofacioskeletal syndrome 4View Disease →
DOID:0080914
Drug Classification
-
ergot alkaloidView Class →
CHEBI:23943
-
Ergot AlkaloidsView Class →
CHEBI:23943
-
t255069
-
t255278
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 3415
- oboInOwl#hasDbXref
- Drug_Central:3184
- core#notation
- CHEBI:59909
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 3415
- oboInOwl#hasDbXref
- Drug_Central:3184
- oboInOwl#id
- CHEBI:59909
- core#notation
- CHEBI:59909
- rxcui
- 318179
- product_type
- HUMAN PRESCRIPTION DRUG
- route
- ORAL
- dosage_form
- TABLET
- marketing_category
- ANDA
- listing_expiration_date
- 20241231
- labeler_name
- Sun Pharmaceutical Industries, Inc.
- manufacturer_name
- Sun Pharmaceutical Industries, Inc.
- marketing_start_date
- 19911031
- package_marketing_start_date
- 19911031
- active_ingredient_name
- DIHYDROERGOCRISTINE MESYLATE
- generic_name
- Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-ergocryptine mesylate, and Dihydro-.beta.-ergocryptine mesylate
- brand_name
- Ergoloid Mesylates
- brand_name_base
- Ergoloid Mesylates
- product_ndc
- 53489-281
- application_number
- ANDA081113
- spl_id
- 273c1270-5303-44f5-be30-0c779d88fea1
- active_ingredient_strength
- .333 mg/1
- package_ndc
- 53489-281-10
- package_description
- 1000 TABLET in 1 BOTTLE, PLASTIC (53489-281-10)
- unii
- DS7CL18UAM
- spl_set_id
- cf973160-d467-4192-a432-04c8c2140369
- upc
- 0353489281010
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#has_parent_hydride
- http://purl.obolibrary.org/obo/CHEBI_36185
- chebi#has_functional_parent
- http://purl.obolibrary.org/obo/CHEBI_4820
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_103766
- BFO_0000051
- http://purl.obolibrary.org/obo/CHEBI_34502
- owl#someValuesFrom
- t849759
- owl#annotatedSource
- t255914